BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28864645)

  • 41. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
    Ahn SJ; Ryu SJ; Joung JY; Lee BR
    Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for Hydroxychloroquine Retinal Toxicity in Indian Patients.
    Dadhaniya NV; Sood I; Patil A; Mallaiah U; Upadhyaya S; Handa R; Gupta SJ
    J Clin Rheumatol; 2021 Dec; 27(8):e395-e398. PubMed ID: 32694356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A
    Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
    Ahn SJ; Joung J; Lim HW; Lee BR
    Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macula pigment optical densitometry changes in hydroxychloroquine use.
    Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
    Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 52. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L; Hu J; Rubin DL; Marmor MF
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 56. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
    Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macular toxicity after short-term hydroxychloroquine therapy.
    Pasaoglu I; Onmez FE
    Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
    Hong EH; Ahn SJ; Lim HW; Lee BR
    BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxychloroquine-induced retinal toxicity in an asymptomatic patient.
    Allard A; Healy R; Bristow E; Hickey S
    Rheumatology (Oxford); 2018 Sep; 57(9):1668. PubMed ID: 29618123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.